Skip to main content
. 2024 Nov 20;15:686. doi: 10.1007/s12672-024-01504-0

Fig. 4.

Fig. 4

Progression-free survival (PFS) based on the tumor microenvironment of recurrent tumor. A PFS based on the immune phenotype (desert vs. non-desert); B PFS based on the immune-desert score